GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kissei Pharmaceutical Co Ltd (TSE:4547) » Definitions » Shiller PE Ratio

Kissei Pharmaceutical Co (TSE:4547) Shiller PE Ratio : 19.85 (As of Mar. 04, 2025)


View and export this data going back to 1988. Start your Free Trial

What is Kissei Pharmaceutical Co Shiller PE Ratio?

As of today (2025-03-04), Kissei Pharmaceutical Co's current share price is 円3690.00. Kissei Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 was 円185.92. Kissei Pharmaceutical Co's Shiller PE Ratio for today is 19.85.

The historical rank and industry rank for Kissei Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

TSE:4547' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.95   Med: 18.44   Max: 29.41
Current: 19.79

During the past years, Kissei Pharmaceutical Co's highest Shiller PE Ratio was 29.41. The lowest was 14.95. And the median was 18.44.

TSE:4547's Shiller PE Ratio is ranked better than
60.3% of 466 companies
in the Drug Manufacturers industry
Industry Median: 23.43 vs TSE:4547: 19.79

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Kissei Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was 円25.860. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is 円185.92 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kissei Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Kissei Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kissei Pharmaceutical Co Shiller PE Ratio Chart

Kissei Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.24 18.29 16.59 15.42 19.41

Kissei Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.70 19.41 17.44 19.07 -

Competitive Comparison of Kissei Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kissei Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Kissei Pharmaceutical Co's Shiller PE Ratio falls into.



Kissei Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Kissei Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=3690.00/185.92
=19.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kissei Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, Kissei Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=25.86/108.9000*108.9000
=25.860

Current CPI (Sep. 2024) = 108.9000.

Kissei Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 59.200 97.900 65.852
201503 -5.845 97.900 -6.502
201506 46.310 98.400 51.252
201509 34.360 98.500 37.988
201512 99.350 98.100 110.288
201603 -13.130 97.900 -14.605
201606 57.940 98.100 64.319
201609 21.580 98.000 23.980
201612 64.441 98.400 71.317
201703 14.136 98.100 15.692
201706 43.500 98.500 48.093
201709 45.098 98.800 49.708
201712 78.050 99.400 85.510
201803 21.256 99.200 23.334
201806 58.670 99.200 64.407
201809 12.758 99.900 13.907
201812 19.970 99.700 21.813
201903 25.920 99.700 28.312
201906 43.080 99.800 47.008
201909 2.954 100.100 3.214
201912 29.790 100.500 32.280
202003 -15.520 100.300 -16.851
202006 36.940 99.900 40.268
202009 57.175 99.900 62.326
202012 43.740 99.300 47.969
202103 -25.045 99.900 -27.301
202106 79.020 99.500 86.485
202109 43.846 100.100 47.701
202112 25.000 100.100 27.198
202203 132.318 101.100 142.527
202206 35.470 101.800 37.944
202209 36.660 103.100 38.722
202212 72.447 104.100 75.787
202303 83.724 104.400 87.333
202306 70.950 105.200 73.445
202309 52.685 106.200 54.024
202312 59.210 106.800 60.374
202403 63.740 107.200 64.751
202406 92.890 108.200 93.491
202409 25.860 108.900 25.860

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kissei Pharmaceutical Co  (TSE:4547) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Kissei Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Kissei Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kissei Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kissei Pharmaceutical Co Headlines

No Headlines